Concord Biotech Limited (BOM:543960)
India · Delayed Price · Currency is INR 1,367.55
+12.90 (0.95%)
At close: Oct 6, 2026
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 143.2 billion as of October 7, 2026. Its market cap has decreased by -15.53% in one year.
Market Cap
143.20B
Enterprise Value
138.88B
Revenue
11.08B
Ranking
n/a
PE Ratio
52.00
Stock Price
1,367.55
ChartMarket Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 143.20B, an increase of 45.18%. That is a compound annual growth rate of 12.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 142.25B | 1.05% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 203.39B |
| Caplin Point Laboratories | 197.91B |
| Jubilant Pharmova | 158.49B |
| AstraZeneca Pharma India | 150.76B |
| Viyash Scientific | 100.06B |
| Procter & Gamble Health | 88.00B |
| Morepen Laboratories | 74.14B |